Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–10 of 10 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
Recruiting
A Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer
NCT06678659
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- City of Hope Duarte, California, United States
- Cleveland Clinic Cleveland, Ohio, United States
- SCRI Oncology Partners - PPDS Nashville, Tennessee, United States
- START Mountain Region West Valley City, Utah, United States
Recruiting
Early Feasibility Clinical Investigation to Assess YntraDose™ as a Neoadjuvant Treatment for LA-PDAC
NCT07155850
- Conditions
- Locally Advanced, Pancreatic Ductal Adenocarcinoma (PDAC), Unresectable
- Locations
-
- Fondazione Policlinico Universitario A. Gemelli, IRCCS Roma, Italy
- Guy's & St Thomas' and Kings College Hospitals London, United Kingdom
Recruiting
PACCELIO - FDG-PET Based Small Volume Accelerated Immuno Chemoradiotherapy in Locally Advanced NSCLC
NCT06102057
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
- Locations
-
- Universitätsklinik Carl Gustav Carus der Technischen Universität Dresden Dresden, Germany
- Universitätsklinikum Essen - Klinik für Strahlentherapie Essen, Germany
- Medical Center - University Of Freiburg, Department of Radiation Oncology Freiburg im Breisgau, Germany
- Universitätsmedizin Göttingen, Department for Radiotherapy and Radiooncology Göttingen, Germany
Recruiting
Study of IBI3005 in Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumors
NCT06418061
- Conditions
- Locally Advanced or Metastatic Solid Tumors, Unresectable
- Locations
-
- Shandong Cancer Hospital & Institute Jinan, Shandong, China
Not Yet Recruiting
A Clinical Trial of Firsekibart, Tislelizumab, and Lenvatinib in Patients With Unresectable, TP53-Mutated Hepatocellular Carcinoma
NCT07535840
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +12 more
- Locations
-
Not specified
NCT03822351
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
- Locations
-
- Research Site Anaheim, California, United States
- Research Site Duarte, California, United States
- Research Site Sacramento, California, United States
- Research Site New Haven, Connecticut, United States
NCT00952003
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Gastric Cancer, +7 more
- Locations
-
- Universitätsklinik Innsbruck Innsbruck, Austria
- A.ö. Landeskrankenhaus Leoben Leoben, Austria
- Krankenhaus der Stadt Linz Linz, Austria
- Universitaetsklinik f. Innere Medizin III Salzburg, Austria
NCT01209676
- Conditions
- Advanced Disease, Melanoma, Neoplasms, +11 more
- Locations
-
- Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States
NCT01216345
- Conditions
- Locally Advanced, Metastatic, Neoplasm Metastasis, +5 more
- Locations
-
- KH Rudolfstiftung Vienna, Austria
Active, Not Recruiting
A Study of Two Dosing Schedules of Atezolizumab in Combination With Gemcitabine and Cisplatin as First-Line Treatment for Metastatic Bladder Cancer
NCT03093922
- Conditions
- Carcinoma, Carcinoma, Transitional Cell, Locally Advanced, +5 more
- Locations
-
- University of Chicago Chicago, Illinois, United States
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen Montvale, New Jersey, United States